ArticleNeurology and therapy2025

Sequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching.

Carolin Luisa Hoehne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.